XML 42 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Earnings (Loss) $ (1,535) $ 196,657
Adjustments to Reconcile Net Earnings (Loss) to Net Cash Provided by Operating Activities, Net of Effect of Non-Cash Activity -    
Depreciation, Depletion, and Amortization 84,944 91,961
Impairment Losses 224,267  
Deferred Income Tax Provision (40,396) 14,552
Stock Compensation Expense 16,407 11,609
Equity in Earnings of Unconsolidated Joint Venture (32,489) (28,931)
Distributions from Joint Venture 25,500 27,500
Changes in Operating Assets and Liabilities:    
Accounts and Notes Receivable (12,171) 4,905
Inventories 36,595 6,899
Accounts Payable and Accrued Liabilities (10,006) (34,964)
Other Assets 4,003 (1,524)
Income Taxes Payable (Receivable) 25,500 5,436
Net Cash Provided by Operating Activities 320,619 294,100
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to Property, Plant, and Equipment (84,056) (126,446)
Acquisition Spending (30,424)  
Proceeds from Sale of Property, Plant, and Equipment   2,281
Net Cash Used in Investing Activities (114,480) (124,165)
CASH FLOWS FROM FINANCING ACTIVITIES    
Increase in Credit Facility 275,000 5,000
Repayment of Private Placement Senior Unsecured Notes (36,500)  
Dividends Paid to Stockholders (13,131) (14,293)
Purchase and Retirement of Common Stock (313,887) (191,800)
Proceeds from Stock Option Exercises 2,996 1,992
Shares Redeemed to Settle Employee Taxes on Stock Compensation (2,963) (1,842)
Net Cash Used in Financing Activities (88,485) (200,943)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 117,654 (31,008)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 8,601 48,068
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 126,255 $ 17,060